JPMorgan upgraded Freshpet (FRPT) to Overweight from Neutral with a price target of $68, up from $66. The stock sold off 9% yesterday following a Q1 sales beat and guidance raise, the analyst tells investors in a research note. The firm expects Freshpet’s sales and EBITDA growth to outpace its staples peers, and does not think the stock’s current valuation sufficiently reflects this. Freshpet could raise its long-term gross margin target when it reports Q2 earnings, JPMorgan contends. A variety of new brands are entering the fresh pet food space, “but consistent with the past, their traction seems to be limited up to this point,” the firm adds.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FRPT:
- Freshpet reports Q1 EPS 91c vs. (26c) last year
- Freshpet sees 2026 revenue growth 8%-11% from $1.1B in 2025, consensus $1.2B
- Freshpet: Buy Rating Reiterated as Strong Momentum Supports Unchanged $80 Price Target
- Freshpet Wins Buy Rating on Strong Q1 Beat, Raised Sales Outlook and Profitable Growth Trajectory
- Freshpet Delivers Strong Q1 Results and Raises Outlook
